NCT01613456View on ClinicalTrials.gov

Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome

NACompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Irritable Bowel Syndrome
Interventions
DIETARY_SUPPLEMENT

Saccharomyces cerevisiae CNCM I-3856

2 capsules/day during 12 weeks

DIETARY_SUPPLEMENT

Placebo

"Capsule with comparable organoleptic properties and weight than the experimental product.~2 capsules/day during 12 weeks"

Trial Locations (1)

44800

Biofortis, Saint-Herblain

Sponsors

Collaborators (1)

BioFortis
All Listed Sponsors
collaborator

BioFortis

OTHER

collaborator

University of Nottingham

OTHER

lead

Lesaffre International

INDUSTRY

NCT01613456 - Effect of Saccharomyces Cerevisiae on the Symptoms of Irritable Bowel Syndrome | Biotech Hunter | Biotech Hunter